Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

From the authors:

Y. Jegal, D. S. Kim
European Respiratory Journal 2009 34: 1004-1005; DOI: 10.1183/09031936.00092909
Y. Jegal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. S. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Tables

  • Table 1—

    Changes in pulmonary function over time for complete case analysis

    SubjectsImprovedStable#Worsened¶
    3 months4422 (50), 22±2116 (36)6 (44), 17±5
    6 months4428 (63), 35±2310 (23)6 (14), 19±6
    1 yr4429 (66), 41±2911 (25)4 (9), 17±4
    2 yrs4426 (59), 48±3012 (27)6 (14), 25±37
    • Data are presented as n, n (%) or mean±sd change in forced vital capacity. #: including patients who maintained a clinically stable condition for many years with no follow-up pulmonary function testing data; ¶: including patients who died or had aggravated cases at the time of follow-up loss.

  • Table 2—

    Changes in pulmonary function over time including missing data

    SubjectsImprovedStable#Worsened¶Missing
    3 months7230 (42)27 (38)14 (19)1 (1)
    6 months7234 (47)22 (31)15 (21)1 (1)
    1 yr7234 (47)20 (28)17 (24)2 (3)
    2 yrs7227 (38)19 (26)18 (25)8 (11)
    • Data are presented as n or n (%). #: including patients who maintained a clinically stable condition for many years with no follow-up PFT data; ¶: including patients who died or had aggravated cases at the time of follow-up loss.

PreviousNext
Back to top
View this article with LENS
Vol 34 Issue 4 Table of Contents
European Respiratory Journal: 34 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
From the authors:
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
From the authors:
Y. Jegal, D. S. Kim
European Respiratory Journal Oct 2009, 34 (4) 1004-1005; DOI: 10.1183/09031936.00092909

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
From the authors:
Y. Jegal, D. S. Kim
European Respiratory Journal Oct 2009, 34 (4) 1004-1005; DOI: 10.1183/09031936.00092909
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • ACKNOWLEGEMENTS
    • Statement of interest
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Refined risk stratification in PAH and timing of lung transplantation
  • COVID-19 drug research and the cohort multiple randomised controlled trial design
  • COVID-19 drug research and the cohort multiple randomised controlled trial design
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society